About the role

Aplyr's Quick Take

This role is about leading payer engagement strategies to support the commercialization of cancer detection technologies. It's a senior management position where you'll oversee a team focused on building relationships with payers and translating clinical data into persuasive narratives. Expect a mix of strategic leadership and hands-on team management.

Good fit

Ideal candidates have extensive experience in payer relationship management and team leadership, likely with a background in healthcare or pharmaceuticals. Strong communication skills and the ability to influence cross-functionally are essential for success.

Worth noting

The role offers a flexible work arrangement but requires at least 40% on-site presence, with specific days encouraged for in-person engagement. The company is in a critical growth phase, which could mean a fast-paced environment with high expectations.

Our mission is to detect cancer early, when it can be cured. We are working to change the trajectory of cancer mortality and bring stakeholders together to adopt innovative, safe, and effective technologies that can transform cancer care.

We are a healthcare company, pioneering new technologies to advance early cancer detection. We have built a multi-disciplinary organization of scientists, engineers, and physicians and we are using the power of next-generation sequencing (NGS), population-scale clinical studies, and state-of-the-art computer science and data science to overcome one of medicine’s greatest challenges.

GRAIL is headquartered in the bay area of California, with locations in Washington, D.C., North Carolina, and the United Kingdom. It is supported by leading global investors and pharmaceutical, technology, and healthcare companies.

For more information, please visit grail.com

GRAIL is seeking a Senior Director, Payer Engagement to lead and scale our payer-facing strategy during a critical phase of commercialization and growth. This individual will manage a team of Account Leads responsible for developing and advancing a robust pipeline of payer engagements, pilots, partnerships, and coverage-enabling activities.

The ideal candidate brings a strong track record of payer relationship management, team leadership, and cross-functional influence, with the ability to translate clinical and economic value into compelling payer narratives.

This role is based in Menlo Park, California, and will move to Sunnyvale, California in Fall 2026. It offers a flexible work arrangement, with the ability to work from GRAIL's office or from home. Our current flexible work arrangement policy requires that a minimum of 40%, or 16 hours, of your total work week be on-site. Your specific schedule, determined in collaboration with your manager, will align with team and business needs and could exceed the 40% requirement for the site. At our Menlo Park campus, Tuesdays and Thursdays are the key days where we encourage on-site presence to engage in events and on-site activities.

Skills & Tags

ai data

Aplyr's read

GRAIL is at the forefront of healthcare innovation, leveraging genomic technology for early cancer detection, attracting talent in engineering, science, and market access.
Synthesized from recent postings & public sources

What's promising

•GRAIL's focus on early cancer detection addresses a critical need in healthcare.
•The company is backed by significant investment, supporting research and development.
•Recent hiring in diverse roles indicates growth and expansion in operations.

What to watch

•The biotechnology sector is highly competitive, with rapid technological advancements.
•Regulatory challenges in healthcare can impact timelines and product launches.
•GRAIL's success heavily depends on the accuracy and reliability of its technology.

Why GRAIL

•GRAIL uses cutting-edge genomic technology for non-invasive cancer detection.
•The company has a strong focus on integrating data science with healthcare.
•GRAIL's mission-driven approach attracts professionals passionate about impactful healthcare solutions.

Aplyr’s read is generated by AI from public sources. Was it useful?